You are viewing an incomplete version of our website. Please click to reload the website as full version.

SLAMF1 antibody (Signaling Lymphocytic Activation Molecule Family Member 1)

Details for Product anti-SLAMF1 Antibody No. ABIN951192, Supplier: Log in to see
Antigen
  • 4933415F16
  • AA177906
  • CD150
  • CDw150
  • ESTM51
  • IPO-3
  • RGD1560634
  • Slam
  • SLAM
  • SLAMF1
Reactivity
Human
179
135
37
3
Host
Mouse
113
98
70
Clonality (Clone)
Monoclonal ()
Conjugate
This SLAMF1 antibody is un-conjugated
28
26
18
9
9
8
6
4
4
4
3
3
3
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
Application
Flow Cytometry (FACS), Immunofluorescence (IF), Immunoprecipitation (IP)
153
75
55
28
22
18
15
15
12
10
9
8
4
3
3
2
2
1
Supplier
Log in to see
Supplier Product No.
Log in to see
Request

Get this product for free

It's quick and easy to submit your validation proposal. I want to validate this product

Learn more

Immunogen Human CD150-transfected 300.19 cells
Clone SLAM-4
Isotype IgG1
Specificity This Monoclonal SLAM.4 antibody recognizes CD150, a cell surface molecule expressed on lymphocytes and involved in their activation.
Cross-Reactivity (Details) Species reactivity (tested):Human.
Purification Protein A-affinity chromatography
Alternative Name CD150 / SLAMF1 (SLAMF1 Antibody Abstract)
Background CD150, also known as SLAM (signaling lymphocyte activation molecule) is a 70-95 kDa single chain transmembrane phosphoglycoprotein of the CD2 family. Its extracellular part contains eight potential N-glycosylation sites, and the intracellular tail contains three unique tyrosine-based motifs. These binding sites can be recognized by SH2-binding phosphatases and the adaptor proteins, such as SAP/SH2D1A or EAT-2. The SLAM family receptors are involved in leucocyte activation and contribute to the effective germinal center formation, generation of high-affinity antibody-secreting plasma cells, and memory T and B cells, thereby facilitating long-term immune response. CD150 expression is upregulated after cell activation.Synonyms: CDw150, Ipo-3, Signaling lymphocytic activation molecule, Slam
Gene ID 6504
NCBI Accession NP_003028
UniProt Q13291
Application Notes Optimal working dilution should be determined by the investigator.
Restrictions For Research Use only
Concentration 1.0 mg/mL (> 95% pure by SDS-PAGE)
Buffer Azide free phosphate buffered saline (PBS), pH ~7.4, 0.2 μm filter sterilized
Preservative Azide free
Handling Advice Avoid repeated freezing and thawing.
Storage 4 °C/-20 °C
Storage Comment Store the antibody at 2 - 8 °C up to one month or (in aliquots) at -20 °C for longer.
Background publications Romero, Zapater, Calvo, Kalko, de la Fuente, Tovar, Ockeloen, Pizcueta, Engel: "CD229 (Ly9) lymphocyte cell surface receptor interacts homophilically through its N-terminal domain and relocalizes to the immunological synapse." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 174, Issue 11, pp. 7033-42, 2005 (PubMed).

Romero, Benítez, March, Vilella, Miralpeix, Engel: "Differential expression of SAP and EAT-2-binding leukocyte cell-surface molecules CD84, CD150 (SLAM), CD229 (Ly9) and CD244 (2B4)." in: Tissue antigens, Vol. 64, Issue 2, pp. 132-44, 2004 (PubMed).

García, Quiroga, Ochoa, Ochoa, Pasquinelli, Fainboim, Olivares, Valdez, Sordelli, Aversa, Modlin, Sieling: "Signaling lymphocytic activation molecule expression and regulation in human intracellular infection correlate with Th1 cytokine patterns." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 167, Issue 10, pp. 5719-24, 2001 (PubMed).